Citation Impact
Citing Papers
Activation and Function of the MAPKs and Their Substrates, the MAPK-Activated Protein Kinases
2011 Standout
Del(6)(q22) and BCL6 Rearrangements in Primary CNS Lymphoma Are Indicators of an Aggressive Clinical Course
2008
Treatment Response Assessment in IDH-Mutant Glioma Patients by Noninvasive 3D Functional Spectroscopic Mapping of 2-Hydroxyglutarate
2015 StandoutNobel
Dual-Specificity Phosphatase 1 Ubiquitination in Extracellular Signal-Regulated Kinase–Mediated Control of Growth in Human Hepatocellular Carcinoma
2008
Membrane Microvesicles as Actors in the Establishment of a Favorable Prostatic Tumoral Niche: A Role for Activated Fibroblasts and CX3CL1-CX3CR1 Axis
2009
IDH1 Mutations as Molecular Signature and Predictive Factor of Secondary Glioblastomas
2009
Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
2009 StandoutScience
A Novel Human AlkB Homologue, ALKBH8, Contributes to Human Bladder Cancer Progression
2009
Amplicon Mapping and Expression Profiling Identify the Fas-Associated Death Domain Gene as a New Driver in the 11q13.3 Amplicon in Laryngeal/Pharyngeal Cancer
2007
Comprehensive molecular portraits of human breast tumours
2012 StandoutNature
Cancer–stromal cell interactions mediated by hypoxia-inducible factors promote angiogenesis, lymphangiogenesis, and metastasis
2012 StandoutNobel
Head and neck squamous cell carcinoma
2020 Standout
Cytokines in inflammatory bowel disease
2014 Standout
N6-Methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO
2011 StandoutNobel
Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
2011 Standout
IDH1 Mutations Are Early Events in the Development of Astrocytomas and Oligodendrogliomas
2009
Frequent copresence of methylated DNA and fragmented nucleosomal DNA in plasma of lymphoma patients
2003
IDH1andIDH2Mutations in Gliomas
2009 Standout
Environmental and health effects of the herbicide glyphosate
2017 Standout
Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq
2012 StandoutNature
Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
2012 Standout
Genetic Pathways to Primary and Secondary Glioblastoma
2007
Signal integration by JNK and p38 MAPK pathways in cancer development
2009 Standout
Grand Challenge Commentary: RNA epigenetics?
2010
Cell Signaling by Receptor Tyrosine Kinases
2010 Standout
Post-transcriptional gene regulation by mRNA modifications
2016 Standout
BRAF and KRAS mutations in prostatic adenocarcinoma
2006
Arrestin Development: Emerging Roles for β-arrestins in Developmental Signaling Pathways
2009 StandoutNobel
Expression and sub‐cellular localization of human ABH family molecules
2007
Inhibition of angiogenesis and invasion in malignant gliomas
2007
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
2009 StandoutNature
The molecular biology of head and neck cancer
2010 Standout
Protein tyrosine phosphatases: from genes, to function, to disease
2006
ROS Function in Redox Signaling and Oxidative Stress
2014 Standout
Epigenetics in Cancer
2008 Standout
Dynamic RNA Modifications in Gene Expression Regulation
2017 Standout
The antiepidermal growth factor receptor monoclonal antibody cetuximab/C225 reduces hypoxia-inducible factor-1 alpha, leading to transcriptional inhibition of vascular endothelial growth factor expression
2005
Discoidin domain receptor tyrosine kinases: new players in cancer progression
2012
Extracellular matrix structure
2015 Standout
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
The chemopreventive agent N-(4-hydroxyphenyl)retinamide induces apoptosis through a mitochondrial pathway regulated by proteins from the Bcl-2 family
2003
Bladder cancer
2016 Standout
Remodelling the extracellular matrix in development and disease
2014 Standout
Transgenerational effects of the endocrine disruptor vinclozolin on the prostate transcriptome and adult onset disease
2008
Malignant Gliomas in Adults
2008 Standout
Mechanisms of drug combinations: interaction and network perspectives
2009 Standout
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Histological variants of urothelial carcinoma: diagnostic, therapeutic and prognostic implications
2009
Human AlkB Homologue 5 Is a Nuclear 2-Oxoglutarate Dependent Oxygenase and a Direct Target of Hypoxia-Inducible Factor 1α (HIF-1α)
2011 StandoutNobel
IFNβ-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage
2013 StandoutNobel
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Microtubule-binding agents: a dynamic field of cancer therapeutics
2010 Standout
Loss-of-Function PTPRD Mutations Lead to Increased STAT3 Activation and Sensitivity to STAT3 Inhibition in Head and Neck Cancer
2015
Regulation of immune responses by extracellular vesicles
2014 Standout
Primary brain tumours in adults
2012 Standout
Interferon-β-1a for the Treatment of Steroid-Refractory Ulcerative Colitis: A Randomized, Double-Blind, Placebo-Controlled Trial
2005
New cancer targets emerging from studies of the Von Hippel‐Lindau tumor suppressor protein
2010 StandoutNobel
N6-methyladenosine-dependent regulation of messenger RNA stability
2013 StandoutNature
Identification of molecular mechanisms for cellular drug resistance by combining drug activity and gene expression profiles
2005
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
2010 Standout
Homozygous Deletions and Recurrent Amplifications Implicate New Genes Involved in Prostate Cancer
2008
Protein Tyrosine Phosphatases in the Human Genome
2004 Standout
Repair of alkylated DNA: Recent advances
2006 StandoutNobel
A decade of exploring the cancer epigenome — biological and translational implications
2011 Standout
Collective cell migration requires suppression of actomyosin at cell–cell contacts mediated by DDR1 and the cell polarity regulators Par3 and Par6
2010
Transcription factor E2F3 overexpressed in prostate cancer independently predicts clinical outcome
2004
Topoisomerase I inhibitors: camptothecins and beyond
2006 Standout
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
2009 StandoutNobel
Evaluation of HIF-1 inhibitors as anticancer agents
2007 StandoutNobel
Eicosapentaenoic acid ameliorates steatohepatitis and hepatocellular carcinoma in hepatocyte-specific Pten-deficient mice
2008 StandoutNobel
Steroidal Androgens and Nonsteroidal, Tissue-Selective Androgen Receptor Modulator, S-22, Regulate Androgen Receptor Function through Distinct Genomic and Nongenomic Signaling Pathways
2008
Primary lymphoma of the central nervous system: just DLBCL or not?
2008
Primary CNS Lymphoma in Immunocompetent Patients
2009
Increased Expression of Genes Converting Adrenal Androgens to Testosterone in Androgen-Independent Prostate Cancer
2006 Standout
Promoter hypermethylation in MLL-r infant acute lymphoblastic leukemia: biology and therapeutic targeting
2010
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
2009 Standout
DNA Methylation and Apoptosis Resistance in Cancer Cells
2013
A genomic perspective on protein tyrosine phosphatases: gene structure, pseudogenes, and genetic disease linkage
2004
Novel Therapy with 2-Methoxyestradiol for the Treatment of Relapsed and Plateau Phase Multiple Myeloma
2007
Discoidin domain receptor 1 is associated with poor prognosis of non-small cell lung carcinomas
2010
Quantitative Methylation-Specific Polymerase Chain Reaction Gene Patterns in Urine Sediment Distinguish Prostate Cancer Patients From Control Subjects
2005
Multimarker Circulating DNA Assay for Assessing Blood of Prostate Cancer Patients
2009
Adverse Health Consequences of Performance-Enhancing Drugs: An Endocrine Society Scientific Statement
2013 Standout
Proteasomal Degradation of Topoisomerase I Is Preceded by c-Jun NH2-Terminal Kinase Activation, Fas Up-Regulation, and Poly(ADP-Ribose) Polymerase Cleavage in SN38-Mediated Cytotoxicity against Multiple Myeloma
2004
Inhibition of Macroautophagy Triggers Apoptosis
2005 Standout
A Review of Activity Indices and Efficacy End Points for Clinical Trials of Medical Therapy in Adults With Ulcerative Colitis
2006 Standout
Works of Eiwa Ishida being referenced
FADD phosphorylation is critical for cell cycle regulation in breast cancer cells
2006
Urothelial carcinoma with plasmacytoid variants producing both human chorionic gonadotropin and carbohydrate antigen 19-9
2006
HRK inactivation associated with promoter methylation and LOH in prostate cancer
2007
Phosphorylation of Fas‐associated Death Domain Contributes to Enhancement of Etoposide‐induced Apoptosis in Prostate Cancer Cells
2002
c-Jun NH2 Terminal Kinase Activation and Decreased Expression of Mitogen-Activated Protein Kinase Phosphatase-1 Play Important Roles in Invasion and Angiogenesis of Urothelial Carcinomas
2007
Prostate cancer antigen‐1 contributes to cell survival and invasion though discoidin receptor 1 in human prostate cancer
2007
Heterogeneous Methylation and Deletion Patterns of the INK4a/ARF Locus Within Prostate Carcinomas
2002
Genetic mapping of allelic loss on chromosome 6q within heterogeneous prostate carcinoma
2003
c‐Jun NH2‐terminal kinase‐dependent fas activation contributes to etoposide‐induced apoptosis in p53‐mutated prostate cancer cells
2003
Frequent LOH on 22q12.3 and TIMP-3 inactivation occur in the progression to secondary glioblastomas
2004
Defective Expression of HRK is Associated with Promoter Methylation in Primary Central Nervous System Lymphomas
2006
Frequent HRK inactivation associated with low apoptotic index in secondary glioblastomas
2005
DNA Hypermethylation Status of Multiple Genes in Prostate Adenocarcinomas
2002
The molecular mechanism of sensitization to Fas‐mediated apoptosis by 2‐methoxyestradiol in PC3 prostate cancer cells
2003
Phosphorylation status of Fas‐associated death domain‐containing protein (FADD) is associated with prostate cancer progression
2005
Contributions of mitogen‐activated protein kinase and nuclear factor kappa B to N‐(4‐hydroxyphenyl)retinamide–induced apoptosis in prostate cancer cells
2002
Novel tumor suppressor loci on 6q22-23 in primary central nervous system lymphomas.
2003
High Expression of a New Marker PCA-1 in Human Prostate Carcinoma
2005
Function of JunB in Transient Amplifying Cell Senescence and Progression of Human Prostate Cancer
2008
Molecular roles of MAP kinases and FADD phosphorylation in prostate cancer.
2006
Frequent alterations of the p14(ARF) and p16(INK4a) genes in primary central nervous system lymphomas.
2001
Interferon-alpha enhances the production of leukotriene B4 in murine peritoneal macrophages stimulated by opsonized zymosan.
1987